Cellular mechanisms regulating human melanogenesis

Cellular and Molecular Life Sciences

Volumn 66, Issue 9, 2009, Pages 1493-1506

  Park, H Y ^a   Kosmadaki, M ^a   Yaar, M ^a   Gilchrest, B A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA damages; Melanocytes; Melanogenesis; Melanosomes; UV

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; DNA; ENDOTHELIN 1; MELANIN; MELANOCORTIN 1 RECEPTOR; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; NEUROTROPHIN; NITRIC OXIDE; PROOPIOMELANOCORTIN; PROTEIN KINASE C BETA; PROTEIN P53; STEM CELL FACTOR;

CELL FUNCTION; CELL TRANSFER; CELL TRANSPORT; DNA DAMAGE; MELANOCYTE; MELANOGENESIS; MELANOSOME; PROTEIN SYNTHESIS; REVIEW; ULTRAVIOLET IRRADIATION;

DNA DAMAGE; HUMANS; KERATINOCYTES; MELANINS; MELANOCYTES; MELANOSOMES; MODELS, BIOLOGICAL; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 67649509828     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-009-8703-8     Document Type: Review

References (187)

1. Ito, S. and Wakamatsu, K. (2003). Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review. Pigment Cell Res. 16, 523-31.
2. Sarangarajan, R. and Apte, S.P. (2006). The polymerization of melanin: a poorly understood phenomenon with egregious biological implications. Melanoma Res. 16, 3-10.
3. Raper,H. S. (1928).The aerobic oxidases. Physiol. Rev. 8, 245.
4. Hearing, V. J. and Jimenez, M. (1987). Mammalian tyrosinase-the critical regulatory control point in melanocyte pigmentation. Int. J. Biochem. 19, 1141-7.
5. Nordlund, J. J. (2002) The value of melanin as a sunscreen. In Mechanisms of Suntanning (Ortonne, J. P., Ballotti, R, ed. eds), pp. 341-361. Martin Dunitz, Ltd., London.
6. Park, H. Y., Pongpudpunth, M., Lee, J., Yaar, M. (2007) Biology of Melanocytes. In Fitzpatrick's Dermatology in General Medicine (Wolff, K., Goldsmith, L. A., Katz, S. I., Gilchrest, B. A., Paller, A. S., Leffell, D. J., ed. eds), pp. 591-608. McGraw Hill, New York.
7. Kadekaro,A. L.,Wakamatsu, K., Ito, S. and Abdel-Malek, Z. A. (2006). Cutaneous photoprotection and melanoma susceptibility: reaching beyond melanin content to the frontiers of DNA repair. Front. Biosci. 11, 2157-73.
8. Eller, M. S., Asarch, A. and Gilchrest, B. A. (2008). Photoprotection in Human Skin-A Multifaceted SOS Response. Photochem. Photobiol. 84, 339-49.
9. Marrot, L., Belaidi, J. P., Meunier, J. R., Perez, P. and Agapakis-Causse, C. (1999). The human melanocyte as a particular target for UVA radiation and an endpoint for photoprotection assessment. Photochem. Photobiol. 69, 686-93.
10. Miyamura, Y., Coelho, S. G., Wolber, R., Miller, S. A., Wakamatsu, K., Zmudzka, B. Z., Ito, S., Smuda,C., Passeron, T.,Choi,W.,Batzer, J.,Yamaguchi,Y.,Beer, J.Z., Hearing,V. J. (2006). Regulation of human skin pigmentation and responses to ultraviolet light. Pigment Cell Res. 20, 2-13.
11. Wenczl, E., Van der Schans, G. P., Roza, L., Kolb, R. M., Timmerman, A. J., Smit, N. P., Pavel, S. and Schothorst, A. A. (1998). (Pheo)melanin photosensitizes UVA-induced DNA damage in cultured human melanocytes. J. Invest. Dermatol. 111, 678-82.
12. Eller, M. S. (1995) Repair of DNA photodamage in human skin. In Photodamage (Gilchrest, B.A., ed. eds), pp. 26-50. Blackwell Scientific Publications, Cambridge, MA.
13. Freeman, S. E., Hacham, H., Gange, R. W., Maytum, D. J., Sutherland, J. C. and Sutherland, B. M. (1989). Wavelength dependence of pyrimidine dimer formation inDNAof human skin irradiated in situ with ultraviolet light. Proc. Natl. Acad. Sci. U S A 86, 5605-9.
14. Parrish, J. A., Jaenicke, K. F. and Anderson, R. R. (1982). Erythema and melanogenesis action spectra of normal human skin. Photochem. Photobiol. 36, 187-91.
15. Gilchrest, B. A., Zhai, S., Eller,M. S., Yarosh,D. B. and Yaar, M. (1993). Treatment of human melanocytes and S91 melanoma cells with the DNA repair enzyme T4 endonucleaseVenhances melanogenesis after ultraviolet irradiation. J. Invest. Dermatol. 101, 666-72.
16. Eller, M. S., Ostrom, K. and Gilchrest, B. A. (1996). DNA damage enhances melanogenesis. Proc.Natl. Acad. Sci.USA 93, 1087-92.
17. Eller, M. S., Yaar, M. and Gilchrest, B. A. (1994). DNA damage and melanogenesis. Nature 372, 413-4.
18. Eller,M. S., Maeda, T.,Magnoni, C., Atwal,D. and Gilchrest, B. A. (1997). Enhancement ofDNArepair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc. Natl. Acad. Sci. U S A 94, 12627-32.
19. Goukassian, D. A., Bagheri, S., el-Keeb, L., Eller, M. S. and Gilchrest, B. A. (2002). DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity. Faseb J. 16, 754-6.
20. Eller, M. S., Puri, N., Hadshiew, I. M., Venna, S. S. and Gilchrest, B. A. (2002). Induction of apoptosis by telomere 3' overhang-specific DNA. Exp. Cell Res. 276, 185-93.
21. Ohashi, N., Yaar, M., Eller,M. S., Truzzi, F. and Gilchrest, B. A. (2008). Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells. J. Cell Physiol. 215, 285.
22. de Lange, T. (1998). Telomeres and senescence: ending the debate. Science 279, 334-5.
23. Blackburn, E. H. (2000). Telomere states and cell fates. Nature 408, 53-6.
24. de Lange, T. (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100-10.
25. Shariftabrizi, A., Eller, M. S., Gilchrest, B. A. (In Press). Telomere homolog oligonucleotides transiently increase telomerase reverse transcriptase (hTERT) levels and elongate telomeres in normal human fibroblasts. J. Invest. Dermatol.
26. Eller, M. S., Liao, X., Liu, S., Hanna, K., Backvall, H., Opresko, P. L., Bohr, V.A. and Gilchrest, B. A. (2006).Arole for WRN in telomere-based DNA damage responses. Proc. Natl. Acad. Sci. U S A 103, 15073-8.
27. Gilchrest, B. A. (2004). Using DNA damage responses to prevent and treat skin cancers. J. Dermatol. 31, 862-77.
28. Nylander, K., Bourdon, J. C., Bray, S. E., Gibbs, N. K., Kay, R.,Hart, I. and Hall,P. A. (2000).Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J. Pathol. 190, 39-46.
29. Khlgatian, M. K.,Hadshiew, I.M., Asawanonda, P.,Yaar,M., Eller, M. S., Fujita, M., Norris, D. A. and Gilchrest, B. A. (2002). Tyrosinase gene expression is regulated by p53. J. Invest. Dermatol. 118, 126-32.
30. Eller,M. S. and Gilchrest, B. A. (2000). Tanning as part of the eukaryoticSOS response. Pigment Cell Res. 13 Suppl 8, 94 -7.
31. Gilchrest, B. A., Park, H. Y., Eller,M. S. and Yaar,M. (1996). Mechanisms of ultraviolet light-induced pigmentation. Photochem. Photobiol. 63, 1-10.
32. Cui, R.,Widlund, H. R., Feige, E., Lin, J. Y.,Wilensky, D. L., Igras, V. E., D'Orazio, J., Fung, C. Y., Schanbacher, C. F., Granter, S. R. and Fisher, D. E. (2007). Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128, 853-64.
33. Slominski, A., Tobin, D. J. and Paus, R. (2007). Does p53 regulate skin pigmentation by controlling proopiomelanocortin gene transcription? Pigment Cell Res. 20, 307-8.
34. Friedmann, P. S. and Gilchrest, B. A. (1987). Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J. Cell Physiol. 133, 88-94.
35. Schallreuter, K. U., Kothari, S., Chavan, B. and Spencer, J. D. (2008). Regulation of melanogenesis - controversies and new concepts. Exp. Dermatol. 17, 395-404
36. Vile, G. F. (1997). Active oxygen species mediate the solar ultraviolet radiation-dependent increase in the tumour suppressor protein p53 in human skin fibroblasts. FEBS Lett 412, 70-4.
37. Gasparro, F. P. (2000). Photodermatology: progress, problems and prospects. Eur. J. Dermatol. 10, 250-4.
38. Punnonen, K. and Yuspa, S. H. (1992). Ultraviolet light irradiation increases cellular diacylglycerol and induces translocation of diacylglycerol kinase in murine keratinocytes. J. Invest. Dermatol. 99, 221-6.
39. Park, H.Y., Perez, J. M., Laursen, R.,Hara, M. and Gilchrest, B. A. (1999). Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J. Biol. Chem. 274, 16470-8.
40. Park, H. Y., Russakovsky, V., Ohno, S. and Gilchrest, B. A. (1993). The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J. Biol. Chem. 268, 11742-9.
41. Blanton, R. A., Kupper, T. S., McDougall, J. K. and Dower, S. (1989). Regulation of interleukin 1 and its receptor in human keratinocytes. Proc. Natl. Acad. Sci. U S A 86, 1273-7.
42. Kock, A., Schwarz, T., Kirnbauer, R., Urbanski,A., Perry, P., Ansel, J. C. and Luger, T.A. (1990). Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172, 1609-14.
43. Slominski, A., Tobin, D. J., Shibahara, S. and Wortsman, J. (2004). Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev. 84, 1155-228.
44. Park, H. Y. and Gilchrest, B. A. (1999). Signaling pathways mediating melanogenesis. Cell Mol. Biol. 45, 919-30.
45. Kwon, B. S., Haq, A. K., Pomerantz, S. H. and Halaban, R. (1987). Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc. Natl. Acad. Sci. U S A 84, 7473-7.
46. Beermann, F., Orlow, S. J., Boissy, R. E., Schmidt, A., Boissy, Y. L. and Lamoreux, M. L. (1995). Misrouting of tyrosinase with a truncated cytoplasmic tail as a result of the murine platinum (cp) mutation. Exp. Eye Res. 61, 599-607.
47. Marles, L. K., Peters, E. M., Tobin, D. J., Hibberts, N. A. and Schallreuter, K. U. (2003). Tyrosine hydroxylase isoenzyme I is present in human melanosomes: a possible novel function in pigmentation. Exp. Dermatol. 12, 61-70.
48. Schweikardt, T.,Olivares, C., Solano, F., Jaenicke, E., Garcia-Borron, J. C. and Decker, H. (2007). A three-dimensional model of mammalian tyrosinase active site accounting for loss of function mutations. Pigment Cell Res. 20, 394-401.
49. Kobayashi, T.,Urabe, K.,Winder,A. (1991). Oxidase activity of TRP-1 and interaction with other melanogenci enzymes. Pigment Cell Res. 7, 227-234.
50. Jackson, I. J., Chambers, D. M., Tsukamoto, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A. and Hearing, V. (1992). A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. Embo. J. 11, 527-35.
51. Kobayashi, T.,Urabe,K.,Winder,A., Jimenez-Cervantes,C., Imokawa,G., Brewington, T., Solano, F., Garcia-Borron, J. C. and Hearing,V. J. (1994). Tyrosinase related protein 1 (TRP1) functions as aDHICAoxidase in melanin biosynthesis. Embo. J. 13, 5818-25.
52. Sturm, R. A., O'Sullivan, B. J., Box, N. F., Smith, A. G., Smit, S. E., Puttick, E. R., Parsons, P. G. and Dunn, I. S. (1995). Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family. Genomics 29, 24-34.
53. Abbott, C., Jackson, I. J., Carritt, B. and Povey, S. (1991). The human homolog of the mouse brown gene maps to the short arm of chromosome 9 and extends the known region of homology with mouse chromosome 4. Genomics 11, 471-3.
54. del Marmol, V. and Beermann, F. (1996). Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett 381, 165-8.
55. Boissy, R. E., Zhao, H., Oetting, W. S., Austin, L. M., Wildenberg, S. C., Boissy, Y. L., Zhao, Y., Sturm, R. A., Hearing, V. J., King, R. A. and Nordlund, J. J. (1996). Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". Am. J. Hum. Genet. 58, 1145-56.
56. Kuzumaki, T., Matsuda, A., Wakamatsu, K., Ito, S. and Ishikawa, K. (1993). Eumelanin biosynthesis is regulated by coordinate expression of tyrosinase and tyrosinase-related protein-1 genes. Exp. Cell. Res. 207, 33-40.
57. del Marmol, V., Ito, S., Jackson, I., Vachtenheim, J., Berr, P., Ghanem, G., Morandini, R., Wakamatsu, K. and Huez, G. (1993). TRP-1 expression correlates with eumelanogenesis in human pigment cells in culture. FEBS Lett. 327, 307-10.
58. Kobayashi, T., Imokawa,G., Bennett,D. C. and Hearing, V. J. (1998). Tyrosinase stabilization by Tyrp1 (the brown locus protein). J. Biol. Chem. 273, 31801-5.
59. Orlow, S. J., Zhou, B. K., Chakraborty, A. K., Drucker, M., Pifko-Hirst, S. and Pawelek, J. M. (1994). High-molecularweight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex. J. Invest. Dermatol. 103, 196-201.
60. Setaluri, V. (2003). The melanosome: dark pigment granule shines bright light on vesicle biogenesis and more. J. Invest. Dermatol. 121, 650-60.
61. Wu, H. and Park, H. Y. (2003). Protein kinase C-betamediated complex formation between tyrosinase and TRP-1. Biochem. Biophys. Res. Commun. 311, 948-53.
62. Pawelek, J. M.,Chakraborty,A.K. (1998).The enzymology of melanogenesis. In The Pigmentary System: Physiology and Pathophysiology (Nordlund, J. J., Boissy,R. E., Hearing,V. J., King, R. A., Ortonne, J. P., ed. eds), pp. 391-400. Oxford University Press, New York.
63. Solano, F., Martinez-Liarte, J. H., Jimenez-Cervantes, C., Garcia-Borron, J. C. and Lozano, J. A. (1994). Dopachrome tautomerase is a zinc-containing enzyme. Biochem. Biophys. Res. Commun. 204, 1243-50.
64. Battaini, F. and Pascale, A. (2005). Protein kinase C signal transduction regulation in physiological and pathological aging. Ann. N. Y. Acad. Sci. 1057, 177-92.
65. Mochly-Rosen, D. (1995). Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268, 247-51.
66. Park, H. Y., Wu, H., Killoran, C. E. and Gilchrest, B. A. (2004). The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. J. Cell Sci. 117, 3659-68.
67. Park, H. Y., Russakovsky, V., Gilchrest, B. A. (1991). Human melanogenesis correlates with expression of the beta isoform of protein kinase C. Clin. Res. 39, 554A.
68. Yasumoto, K., Yokoyama, K., Takahashi, K., Tomita, Y. and Shibahara, S. (1997). Functional analysis of microphthalmiaassociated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J. Biol. Chem. 272, 503-9.
69. Goding, C. R. (2000). Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev. 14, 1712-28.
70. Park, H. Y., Wu, C., Yonemoto, L., Murphy-Smith, M., Wu, H., Stachur,C.M. and Gilchrest,B. A. (2006).MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. Biochem. J. 395, 571-8.
71. Steingrimsson, E., Copeland, N. G. and Jenkins, N. A. (2004). Melanocytes and the microphthalmia transcription factor network. Annu. Rev. Genet. 38, 365-411.
72. Shibahara, S., Takeda, K., Yasumoto, K., Udono, T., Watanabe, K., Saito,H. and Takahashi,K. (2001). Microphthalmiaassociated transcription factor (MITF): multiplicity in structure, function, and regulation. J. Investig. Dermatol. Symp Proc. 6, 99 -104.
73. Hershey, C. L. and Fisher, D. E. (2005). Genomic analysis of the Microphthalmia locus and identification of the MITF-J/ Mitf-J isoform. Gene 347, 73-82.
74. Du, J., Miller, A. J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S. and Fisher, D. E. (2003). MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITFin melanocytes and melanoma. Am.J. Pathol. 163, 333-43.
75. Fuse, N., Yasumoto, K., Suzuki, H., Takahashi, K. and Shibahara, S. (1996). Identification of a melanocyte-type promoter of the microphthalmia- associated transcription factor gene. Biochem. Biophys. Res. Commun. 219, 702-7.
76. Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T. and Fisher,D. E. (1998).MAPkinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391, 298-301.
77. Price, E. R., Ding, H. F., Badalian, T., Bhattacharya, S., Takemoto, C., Yao, T. P., Hemesath, T. J. and Fisher, D. E. (1998). Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J. Biol. Chem. 273, 17983-6.
78. Wu, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M. A., Wells, A. G., Price, E. R., Fisher, D. Z. and Fisher, D. E. (2000). c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14, 301-12.
79. Xu, W., Gong, L., Haddad, M. M., Bischof, O., Campisi, J., Yeh, E. T. and Medrano, E. E. (2000). Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp. Cell Res. 255, 135-43.
80. Chiaverini, C., Beuret, L., Flori, E.,Busca, R.,Abbe, P., Bille, K., Bahadoran, P., Ortonne, J. P., Bertolotto, C. and Ballotti, R. (2008). Microphthalmia associated transcription factor (MITF regulates rab27A gene expression and controls melanosomes transport. J. Biol. Chem. 283, 12635-42.
81. Mountjoy, K. G., Robbins, L. S., Mortrud, M. T. and Cone, R. D. (1992). The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-51.
82. Luger, T.A., Scholzen, T. and Grabbe, S. (1997). The role of alpha-melanocyte-stimulating hormone in cutaneous biology. J. Investig. Dermatol. Symp. Proc. 2, 87-93.
83. Rouzaud, F., Kadekaro, A. L., Abdel-Malek, Z. A. and Hearing, V. J. (2005). MC1R and the response of melanocytes to ultraviolet radiation. Mutat. Res. 571, 133-52.
84. Kadekaro,A. L., Kanto,H., Kavanagh, R. and Abdel-Malek, Z. A. (2003). Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival. Ann. N. Y. Acad. Sci. 994, 359-65.
85. Suzuki, I., Cone,R.D., Im, S., Nordlund, J. and Abdel-Malek, Z. A. (1996). Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137, 1627-33.
86. Ha, T., Naysmith, L., Waterston, K., Oh, C., Weller, R. and Rees, J. L. (2003). Defining the quantitative contribution of the melanocortin 1 receptor (MC1R) to variation in pigmentary phenotype. Ann. N. Y. Acad. Sci. 994, 339-47.
87. Sturm, R. A., Teasdale, R. D. and Box, N. F. (2001). Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 277, 49-62.
88. Schaffer, J. V. and Bolognia, J. L. (2001). The melanocortin-1 receptor: red hair and beyond. Arch. Dermatol. 137, 1477-85.
89. Sturm, R. A., Duffy, D. L., Box, N. F., Chen, W., Smit, D. J., Brown, D. L., Stow, J. L., Leonard, J. H. and Martin, N. G. (2003). The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res. 16, 266-72.
90. Valverde, P., Healy, E., Jackson, I.,Rees, J. L. and Thody,A. J. (1995). Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet. 11, 328-30.
91. Smith, R.,Healy,E., Siddiqui, S., Flanagan,N., Steijlen, P. M., Rosdahl, I., Jacques, J. P., Rogers, S., Turner,R., Jackson, I. J., Birch-Machin, M. A. and Rees, J. L. (1998). Melanocortin 1 receptor variants in an Irish population. J. Invest. Dermatol. 111, 119-22.
92. Flanagan, N., Ray, A. J., Todd, C., Birch-Machin, M. A. and Rees, J. L. (2001). The relation between melanocortin 1 receptor genotype and experimentally assessed ultraviolet radiation sensitivity. J. Invest. Dermatol. 117, 1314-7.
93. Healy, E., Flannagan, N., Ray, A., Todd, C., Jackson, I. J., Matthews, J. N., Birch-Machin, M. A. and Rees, J. L. (2000). Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 355, 1072-3.
94. Bastiaens, M., ter Huurne, J., Gruis, N., Bergman, W., Westendorp, R., Vermeer, B. J. and Bouwes Bavinck, J. N. (2001). Themelanocortin-1-receptor gene is the major freckle gene. Hum. Mol. Genet. 10, 1701-8.
95. Box, N. F., Wyeth, J. R., O'Gorman, L. E., Martin, N. G. and Sturm, R. A. (1997). Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum. Mol. Genet. 6, 1891-7.
96. Hauser, J. E., Kadekaro, A. L., Kavanagh, R. J.,Wakamatsu, K., Terzieva, S., Schwemberger, S., Babcock, G., Rao, M. B., Ito, S. and Abdel-Malek, Z. A. (2006). Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. Pigment Cell Res. 19, 303-14.
97. Stratigos, A. J., Dimisianos, G., Nikolaou, V., Poulou, M., Sypsa, V., Stefanaki, I., Papadopoulos, O., Polydorou, D., Plaka, M.,Christofidou, E.,Gogas,H., Tsoutsos,D., Kastana, O.,Antoniou,C.,Hatzakis,A., Kanavakis,E. and Katsambas, A. D. (2006). Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J. Invest. Dermatol. 126, 1842-9.
98. Lu, D., Willard, D., Patel, I. R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W., Woychik, R. P., Wilkison, W. O. (1994). Agouti protein is an antagonist of the melanocytestimulating-hormone receptor. Nature 371, 799-802.
99. Ollmann, M. M., Wilson, B. D., Yang, Y. K., Kerns, J. A., Chen, Y., Gantz, I. and Barsh, G. S. (1997). Antagonism of central melanocortin receptors in vitro and in vivo by agoutirelated protein. Science 278, 135-8.
100. Siegrist, W., Drozdz, R., Cotti, R., Willard, D. H., Wilkison, W. O. and Eberle, A. N. (1997). Interactions of alphamelanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. J. Recept. Signal Transduct. Res. 17, 75-98.
101. Candille, S. I., Kaelin, C. B., Cattanach, B. M., Yu, B., Thompson, D. A., Nix, M. A., Kerns, J. A., Schmutz, S. M., Millhauser,G.L. and Barsh,G. S. (2007). A-defensin mutation causes black coat color in domestic dogs. Science 318, 1418-23.
102. Dorin, J. R. and Jackson, I. J. (2007). Genetics. Beta-defensin repertoire expands. Science 318, 1395.
103. Slominski, A., Plonka, P. M., Pisarchik, A., Smart, J. L., Tolle, V., Wortsman, J. and Low, M. J. (2005). Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background. Endocrinology 146, 1245-53.
104. Gillbro, J.M., Marles, L. K., Hibberts, N.A. and Schallreuter, K. U. (2004). Autocrine catecholamine biosynthesis and the beta-adrenoceptor signal promote pigmentation in human epidermal melanocytes. J. Invest. Dermatol. 123, 346-53.
105. Grando, S.A., Pittelkow,M.R. and Schallreuter, K.U. (2006). Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J. Invest. Dermatol. 126, 1948-65.
106. Kauser, S., Schallreuter, K. U., Thody, A. J., Gummer, C. and Tobin, D. J. (2003). Regulation of human epidermal melanocyte biology by beta-endorphin. J. Invest. Dermatol. 120, 1073-80.
107. Raposo, G. and Marks, M. S. (2002). The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis. Traffic 3, 237-48.
108. Raposo, G., Tenza, D., Murphy, D. M., Berson, J. F. and Marks, M. S. (2001). Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells. J. Cell Biol. 152, 809-24.
109. Kushimoto, T., Basrur, V., Valencia, J.,Matsunaga, J., Vieira, W. D., Ferrans, V. J., Muller, J., Appella, E. and Hearing, V. J. (2001). A model for melanosome biogenesis based on the purification and analysis of early melanosomes. Proc. Natl. Acad. Sci. U S A 98, 10698-703.
110. Hearing, V. J. (2005). Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J. Dermatol. Sci. 37, 3-14.
111. Hara, M.,Yaar,M., Byers,H.R., Goukassian,D., Fine,R. E., Gonsalves, J. and Gilchrest, B.A. (2000). Kinesin participates in melanosomal movement along melanocyte dendrites. J. Invest. Dermatol. 114, 438-43.
112. Hirokawa, N., Sato-Yoshitake, R., Kobayashi, N., Pfister, K. K., Bloom, G. S. and Brady, S. T. (1991). Kinesin associates with anterogradely transported membranous organelles in vivo. J. Cell. Biol. 114, 295-302.
113. Okada, Y., Yamazaki, H., Sekine-Aizawa, Y. and Hirokawa, N. (1995). The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell 81, 769-80.
114. Bloom, G. S. (1992). Motor proteins for cytoplasmic microtubules. Curr Opin Cell Biol 4, 66-73.
115. Byers, H. R., Yaar, M., Eller, M. S., Jalbert, N. L. and Gilchrest, B. A. (2000). Role of cytoplasmic dynein in melanosome transport in human melanocytes. J. Invest. Dermatol. 114, 990-7.
116. Coy, D. L. and Howard, J. (1994). Organelle transport and sorting in axons. Curr. Opin. Neurobiol. 4, 662-7.
117. Endow, S. A. and Titus, M. A. (1992). Genetic approaches to molecular motors. Annu. Rev. Cell. Biol. 8, 29-66.
118. Gelfand, V. I. and Scholey, J. M. (1992). Cell biology. Every motion has its motor. Nature 359, 480-2.
119. Wu, X., Bowers, B., Rao, K.,Wei, Q. and Hammer, J. A., 3rd. (1998). Visualization of melanosome dynamics within wildtype and dilute melanocytes suggests a paradigm for myosinV function In vivo. J. Cell Biol. 143, 1899-918.
120. Matesic, L. A., Copeland, N. G., Jenkins, N. A. (2002) A genetic approach to the study of vesicle transport in the mouse. InMechanisms of Suntanning (Ortonne, J.P., Ballotti, R, ed. eds), pp. 199-208. Martin Dunitz, Nice.
121. Van Den Bossche, K., Naeyaert, J. M. and Lambert, J. (2006). The quest for the mechanism of melanin transfer. Traffic
122. Scott, G., Leopardi, S., Printup, S. and Madden, B. C. (2002). Filopodia are conduits for melanosome transfer to keratinocytes. J. Cell Sci. 115, 1441-51.
123. Nystedt, S., Emilsson, K., Wahlestedt, C. and Sundelin, J. (1994). Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. U S A 91, 9208-12.
124. Nystedt, S., Emilsson, K., Larsson, A. K., Strombeck, B. and Sundelin, J. (1995). Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur. J. Biochem. 232, 84 -9.
125. Scott,G.,Deng,A., Rodriguez-Burford,C., Seiberg,M., Han, R., Babiarz, L.,Grizzle,W., Bell,W. and Pentland, A. (2001). Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation. J. Invest. Dermatol. 117, 1412-20.
126. Cardinali, G., Ceccarelli, S., Kovacs, D., Aspite, N., Lotti, L. V., Torrisi, M. R. and Picardo,M. (2005). Keratinocyte growth factor promotes melanosome transfer to keratinocytes. J. Invest. Dermatol. 125, 1190-9.
127. Archambault, M., Yaar, M. and Gilchrest, B. A. (1995). Keratinocytes and fibroblasts in a human skin equivalent model enhance melanocyte survival and melanin synthesis after ultraviolet irradiation. J. Invest. Dermatol. 104, 859-67.
128. Wintzen, M., Yaar, M., Aila, E., Verneer, B. J., Gilchrest, B. A. (1995). Keratinocytes produce beta-endorphin and betalipotropic hormone after stimulation byUV, IL-1a or phorbol esters. J. Invest. Dermatol. 104, 641.
129. Schauer, E., Trautinger, F., Kock, A., Schwarz, A., Bhardwaj, R., Simon, M., Ansel, J. C., Schwarz, T. and Luger, T. A. (1994). Proopiomelanocortin- derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest. 93, 2258-62.
130. Lerner, A. B. and McGuire, J. S. (1961). Effect of alpha- and beta melanocyte stimulating hormones on the skin colour of man. Nature 189, 176-9.
131. Levine, N., Sheftel, S. N., Eytan, T., Dorr, R. T., Hadley, M. E., Weinrach, J. C., Ertl, G. A., Toth, K., McGee, D. L. and Hruby,V. J. (1991). Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. Jama 266, 2730-6.
132. Jabbour, S. A. (2003). Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am. J. Clin. Dermatol. 4, 315-31.
133. Assie, G., Bahurel, H., Bertherat, J., Kujas, M., Legmann, P. and Bertagna, X. (2004). The Nelson's syndrome... revisited. Pituitary 7, 209-15.
134. Slominski, A.,Wortsman, J., Luger, T., Paus,R. and Solomon, S. (2000). Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80, 979-1020.
135. Schallreuter, K. U., Wood, J. M., Pittelkow M. R., GÜtlich, M., Lemke, K. R., Rçdl, W. Swanson, N. N., Hitzemann, K., Ziegler, I. (1994). Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263, 1444-6.
136. Schallreuter, K.U. (1999).Areview of recent advances on the regulation of pigmentation in the human epidermis. Cell Mol Biol (Noisy-le-grand) 45, 943-9.
137. Spencer, J. D., Chavan, B., Marles, L. K., Kauser, S., Rokos, H. and Schallreuter, K. U. (2005). A novel mechanism in control of human pigmentation by {beta}-melanocyte-stimulating hormone and 7-tetrahydrobiopterin. J. Endocrinol. 187, 293-302.
138. Yada, Y., Higuchi, K. and Imokawa, G. (1991). Effects of endothelins on signal transduction and proliferation in human melanocytes. J. Biol. Chem. 266, 18352-7.
139. Imokawa,G., Yada, Y. and Miyagishi, M. (1992). Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J. Biol. Chem. 267, 24675-80.
140. Hara, M., Yaar, M. and Gilchrest, B. A. (1995). Endothelin-1 of keratinocyte origin is a mediator of melanocyte dendricity. J. Invest. Dermatol. 105, 744-8.
141. Yohn, J. J.,Morelli, J.G.,Walchak, S. J.,Rundell, K.B.,Norris, D. A. and Zamora, M. R. (1993). Cultured human keratinocytes synthesize and secrete endothelin-1. J. Invest. Dermatol. 100, 23 -6.
142. Funasaka, Y., Chakraborty, A. K., Hayashi, Y., Komoto, M., Ohashi, A., Nagahama, M., Inoue, Y., Pawelek, J. and Ichihashi, M. (1998). Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha. Br. J. Dermatol. 139, 216-24.
143. Tada, A., Suzuki, I., Im, S., Davis, M. B., Cornelius, J., Babcock, G., Nordlund, J. J. and Abdel-Malek, Z. A. (1998). Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ. 9, 575-84.
144. Imokawa, G., Kobayasi, T. and Miyagishi, M. (2000). Intracellular signaling mechanisms leading to synergistic effects of endothelin-1 and stem cell factor on proliferation of cultured human melanocytes. Cross-talk via trans-activation of the tyrosine kinase c-kit receptor. J. Biol. Chem. 275, 33321-8.
145. Hachiya, A., Kobayashi, A., Ohuchi, A., Takema, Y. and Imokawa, G. (2001). The paracrine role of stem cell factor/ckit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation. J. Invest. Dermatol. 116, 578-86.
146. Tomita,Y.,Maeda, K. and Tagami, H. (1989). Mechanisms for hyperpigmentation in postinflammatory pigmentation, urticaria pigmentosa and sunburn. Dermatologica 179 Suppl 1, 49-53.
147. Gilchrest, B. A., Soter, N. A., Stoff, J. S. and Mihm,M. C., Jr. (1981). The human sunburn reaction: histologic and biochemical studies. J. Am. Acad. Dermatol. 5, 411-22.
148. Ruzicka, T. (1989). Leukotrienes in atopic eczema. Acta Derm Venereol Suppl (Stockh) 144, 48-9.
149. Ikai, K. (1999). Psoriasis and the arachidonic acid cascade. J. Dermatol. Sci. 21, 135-46.
150. Scott,G., Leopardi, S., Printup, S., Malhi, N., Seiberg,M. and Lapoint, R. (2004). Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity. J. Invest. Dermatol. 122, 1214-24.
151. Scott, G., Jacobs, S., Leopardi, S., Anthony, F. A., Learn, D., Malaviya, R. and Pentland, A. (2005). Effects of PGF2alpha on human melanocytes and regulation of the FP receptor by ultraviolet radiation. Exp. Cell Res. 304, 407-16.
152. Norris, D. A., Morelli, J. G., Fujita, M. (1998) Melanocytes interactions in skin. In The Pigmentary System: Physiology and Pathophysiology (Nordlund, J.J., Boissy, R.E., Hearing, V.J.,King,R.A., Ortonne, J. P., ed. eds), pp. 123-133. Oxford Univ. Press, New York.
153. Gantz, I., Munzert, G., Tashiro, T., Schaffer, M., Wang, L., DelValle, J. and Yamada, T. (1991). Molecular cloning of the human histamine H2 receptor. Biochem. Biophys. Res. Commun. 178, 1386-92.
154. Yoshida, M., Takahashi, Y. and Inoue, S. (2000). Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes. J. Invest. Dermatol. 114, 334-42.
155. Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science 237, 1154-62.
156. Hohn, A., Leibrock, J., Bailey, K. and Barde, Y. A. (1990). Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344, 339-41.
157. Maisonpierre, P. C., Belluscio, L., Squinto, S., Ip, N. Y., Furth, M. E., Lindsay, R. M. and Yancopoulos, G. D. (1990). Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 247, 1446-51.
158. Rosenthal, A., Goeddel, D. V., Nguyen, T., Lewis, M., Shih, A., Laramee, G. R., Nikolics, K. and Winslow, J. W. (1990). Primary structure and biological activity of a novel human neurotrophic factor. Neuron 4, 767-73.
159. Hallbook, F., Ibanez, C. F. and Persson, H. (1991). Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 6, 845-58.
160. Barde, Y. A., Edgar, D. and Thoenen, H. (1982). Purification of a new neurotrophic factor from mammalian brain. Embo. J. 1, 549-53.
161. Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masiakowski, P., Thoenen, H. and Barde, Y. A. (1989). Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341, 149-52.
162. Peacocke, M., Yaar, M., Mansur, C. P., Chao, M. V. and Gilchrest, B. A. (1988). Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci U S A 85, 5282-6.
163. Botchkarev, V. A., Yaar, M., Peters, E. M., Raychaudhuri, S. P., Botchkareva, N. V., Marconi, A., Raychaudhuri, S. K., Paus,R. and Pincelli,C. (2006). Neurotrophins in skin biology and pathology. J. Invest. Dermatol. 126, 1719-27.
164. Yaar, M.,Grossman, K., Eller, M. and Gilchrest,B. A. (1991). Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J. Cell Biol. 115, 821-8.
165. Zhai, S., Yaar, M., Doyle, S. M. and Gilchrest, B. A. (1996). Nerve growth factor rescues pigment cells from ultravioletinduced apoptosis by upregulating BCL-2 levels. Exp. Cell Res. 224, 335-43.
166. Stefanato, C. M., Yaar, M., Bhawan, J., Phillips, T. J., Kosmadaki, M. G., Botchkarev, V. and Gilchrest, B. A. (2003). Modulations of nerve growth factor and Bcl-2 in ultraviolet-irradiated human epidermis. J. Cutan. Pathol. 30, 351-7.
167. Halaban, R., Ghosh, S. and Baird, A. (1987). bFGF is the putative natural growth factor for human melanocytes. In Vitro Cell Dev. Biol. 23, 47-52.
168. Halaban, R., Langdon, R., Birchall, N., Cuono, C., Baird, A., Scott, G., Moellmann, G. and McGuire, J. (1988). Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J. Cell Biol. 107, 1611-9.
169. Moncada, S., Palmer, R. M. and Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-42.
170. Schmidt, H. H. and Walter, U. (1994). NO at work. Cell 78, 919-25.
171. Joshi, M., Strandhoy, J. and White, W. L. (1996). Nitric oxide synthase activity is up-regulated in melanoma cell lines: a potential mechanism for metastases formation. Melanoma Res. 6, 121-6.
172. Heck, D. E., Laskin, D. L., Gardner, C. R. and Laskin, J. D. (1992). Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J. Biol. Chem. 267, 21277-80.
173. Becherel, P. A., Mossalayi, M. D., Ouaaz, F., Le Goff, L., Dugas, B., Paul-Eugene, N., Frances, C., Chosidow, O., Kilchherr, E., Guillosson, J. J. (1994). Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes. J. Clin. Invest. 93, 2275-9.
174. Fecker, L. F., Eberle, J., Orfanos, C. E. and Geilen, C. C. (2002). Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide. J. Invest. Dermatol. 118, 1019-25.
175. Romero-Graillet, C., Aberdam, E., Clement, M., Ortonne, J. P. and Ballotti, R. (1997). Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J. Clin. Invest. 99, 635-42.
176. Martini, F. H. (1998) Fundamentals of Anatomy and Physiology: The Endocrine System, Prentice Hall International. Upper Saddle River, NJ.
177. Farooqui, J. Z., Robb, E., Boyce, S. T., Warden, G. D. and Nordlund, J. J. (1995). Isolation of a unique melanogenic inhibitor from human skin xenografts: initial in vitro and in vivo characterization. J. Invest. Dermatol. 104, 739-43.
178. Vijayan, E.,Husain, I.,Ramaiah, A. and Madan,N. C. (1982). Purification of human skin tyrosinase and its protein inhibitor: properties of the enzyme and the mechanism of inhibition by protein. Arch. Biochem. Biophys. 217, 738-47.
179. Hoekstra, D., Maier, O., van der Wouden, J. M., Slimane, T. A. and van, I. S. C. (2003). Membrane dynamics and cell polarity: the role of sphingolipids. J. Lipid Res. 44, 869-77.
180. Kim, E. J., Park, H. Y., Yaar, M. and Gilchrest, B. A. (2005). Modulation of vascular endothelial growth factor receptors in melanocytes. Exp. Dermatol. 14, 625-33.
181. Kim, D. S., Kim, S. Y., Chung, J. H., Kim, K. H., Eun, H. C. and Park, K. C. (2002). Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal. 14, 779-85.
182. Yaar, M., Wu, C., Park, H. Y., Panova, I., Schutz, G. and Gilchrest, B. A. (2006). Bone morphogenetic protein-4: A novel modulator of melanogenesis. J. Biol. Chem. 281, 25307-25314.
183. Park, H. Y., Stachur, C., Wang, F., Gilchrest, B. A. (2007). BMP-4 regulation of MITF expression in cultured human melanocytes. J. Invest. Dermatol. 127, 916A.
184. Sharov, A. A., Fessing, M., Atoyan, R., Sharova, T. Y., Haskell-Luevano, C., Weiner, L., Funa, K., Brissette, J. L., Gilchrest, B. A. and Botchkarev, V. A. (2005). Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway. Proc. Natl. Acad. Sci. U S A 102, 93-8.
185. Moore, J., Wood, J. M. and Schallreuter, K. U. (1999). Evidence for specific complex formation between alphamelanocyte stimulating hormone and 6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin using near infrared Fourier transform Raman spectroscopy. Biochemistry 38, 15317-24.
186. Schallreuter, K. U., Wood, J. M., Ziegler, I., Lemke, K. R., Pittelkow, M. R., Lindsey, N. J. and Gutlich, M. (1994). Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim. Biophys. Acta. 1226, 181-92.
187. Wood, J. M., Schallreuter-Wood, K. U., Lindsey, N. J., Callaghan, S. and Gardner, M. L. (1995). A specific tetrahydrobiopterin binding domain on tyrosinase controls melanogenesis. Biochem. Biophys. Res. Commun. 206, 480-5.